These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 15055275

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral graft-versus-host disease.
    Schubert MM, Correa ME.
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 11. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A, Salooja N, Russell-Jones R.
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [Abstract] [Full Text] [Related]

  • 12. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
    Nagler RM, Nagler A.
    Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066
    [Abstract] [Full Text] [Related]

  • 13. Oral patterns of acute and chronic graft-v-host disease.
    Barrett AP, Bilous AM.
    Arch Dermatol; 1984 Nov; 120(11):1461-5. PubMed ID: 6388506
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Life-threatening graft-vs-host disease.
    Vargas-Díez E, García-Díez A, Marín A, Fernández-Herrera J.
    Clin Dermatol; 2005 Nov; 23(3):285-300. PubMed ID: 15896544
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R.
    Clin Transpl; 2003 Nov; ():275-82. PubMed ID: 15387119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.